Quantum Financial Partners’s Autolus Therapeutics AUTL Stock Holding History

Quantum Financial Partners’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-18,795	Closed	-$30.1K	–	154
2026 Q2	$30.1K	Buy	+18,795	New	+$29.5K	0.02%	153

Other funds holding AUTL

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $3.43B AUM 16.22% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 63.53% 1-Year Est. Return

Meridian Financial Partners Warrenton, Virginia $306M AUM 22.08% 1-Year Est. Return

Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Quantum Financial Partners's AUTL Position: Q3 2026 in Review

Quantum Financial Partners sold out of Autolus Therapeutics (AUTL) in Q3 2026, closing a stake of 18,795 shares — an estimated $30.1K sold.

Quantum Financial Partners first reported a position in AUTL in Q2 2026 and held it in 1 quarter. The position peaked at $30.1K in Q2 2026. 8 funds tracked by Wall St. Rank hold AUTL as of Q3 2026.

Quantum Financial Partners reported no remaining Autolus Therapeutics position as of Q3 2026 after selling out during the quarter.
Quantum Financial Partners sold 18,795 Autolus Therapeutics shares in Q3 2026, an estimated $30.1K.
Quantum Financial Partners first reported a position in Autolus Therapeutics in Q2 2026 and held it in 1 quarter.
Quantum Financial Partners's Autolus Therapeutics position peaked at $30.1K in Q2 2026.
8 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2026.

Based on Quantum Financial Partners's 13F filing for Q3 2026, filed 19 Oct 2026.